Ph.D. in human pathology from the Federal University of Bahia (UFBA) and is a public health researcher at the Gonçalo Moniz Institute (Fiocruz-BA) and IDOR. His research focuses on cell therapy, regenerative medicine, gene editing, CRISPR/Cas9 technology, and biomarker studies.
